Cutaneous Oncology

Digital Education Hubs

Return to Digital Educational Hub
Return to Digital Educational Hub

Upcoming LIVE Sessions

Aaron S. Earbera MD

Come see me speak at
SBS: West Coast Derm

SATURDAY OCTOBER 15 2022
  • 10:50-11:05 AM
  • New Methods for Detection of Melanoma and NMSC
  • 11:45 AM-12:00 PM
  • Beyond the Scalpel: Radiation Therapies for Cutaneous Malignancies
Natasha A. Mesinkovska MD

Come see me speak at
SBS: West Coast Derm

SATURDAY OCTOBER 15 2022
  • 11:20-11:30 AM
  • Protection in a Bottle: Sunscreen Controversies
Todd E. Schlesinger MD

Come see me speak at
SBS: West Coast Derm

SATURDAY OCTOBER 15 2022
  • 11:05-11:20 AM
  • Game-Changers: PD-1 Inhibitors for Melanoma and NMSC
  • 11:30-11:45 AM
  • Staying Ahead: Advances in Treatment of Actinic Keratoses

Virtual Symposia/Webcasts

CUTANEOUS ONCOLOGY SYMPOSIUM: Updating Guidance for dermatology
Get Started

Session Slides

SBS 2022
Novel Approaches to Treating Actinic Keratosis
Todd Schlesinger, MD
Download
SBS 2022
Spotlight on Sunscreen
David Goldberg, MD, JD
Download
SBS 2022
Non-invasive Detection for Melanoma
Laura Ferris, MD
Download
SBS 2022
Genetic Approaches to the Prognosis of Melanoma
Aaron Farberg, MD
Download
SBS 2022
Treatment Guidelines For Melanoma And Non-Melanoma Skin Cancer
David Goldberg, MD, JD
Download
SBS 2022
Hedgehog Inhibitors for BCC: Tips and Tricks
Aaron Farberg, MD
Download
SBS 2022
Radiation Therapies
David Goldberg, MD, JD
Download
SBS 2022
Clinical Updates on PD-1 Inhibitors for cSCC
Todd Schlesinger, MD
Download

Peer-to-Peer Education Toolkit

Cutaneous Oncology 2022 Education Toolkit
Get Started

Clinician Resources

1
The National Comprehensive Cancer Network (NCCN) guidelines for the management of cutaneous melanoma
2
The National Comprehensive Cancer Network (NCCN) guidelines for the management of basal cell carcinoma
3
The National Comprehensive Cancer Network (NCCN) guidelines for the management of squamous cell carcinoma
4
AK clinical management guidelines from the American Academy of Dermatology
5
AK clinical evidence for diagnosis as offered by the American Academy of Dermatology Association
6
Patient reported outcomes (PROs) and unmet needs in AK as identified by the National Center for Biotechnology Information
7
Cutaneous squamous cell carcinoma clinical guidelines offered by the American Academy of Dermatology Association
8
Risk assessment considerations for cutaneous squamous carcinoma as postulated by the American Academy of Dermatology Association
9
The National Comprehensive Cancer Network (NCCN) guidelines for the management of merkel cell carcinoma
10
The National Comprehensive Cancer Network (NCCN) guidelines for the management of dermatofibrosarcoma protuberans
11
The National Comprehensive Cancer Network (NCCN) guidelines for the management of primary cutaneous lymphomas